Clene Inc. SEC filings CLNN

Clene Inc. has 707 filings in SEC EDGAR's recent list, going back to Sep 10, 2020. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Clene Inc. SEC filings
Form Description Filed Period
424B5 Prospectus supplement Sep 16, 2026 —
S-8 Employee stock plan registration Jun 5, 2026 —
424B5 Prospectus supplement May 5, 2026 —
424B5 Prospectus supplement May 5, 2026 —
424B5 Prospectus supplement Jan 9, 2026 —
424B5 Prospectus supplement Oct 17, 2025 —
424B3 Prospectus Sep 12, 2025 —
424B5 Prospectus supplement Sep 5, 2025 —
S-3 Shelf registration Sep 5, 2025 —
S-8 Employee stock plan registration Sep 5, 2025 —
424B5 Prospectus supplement Jul 3, 2025 —
424B5 Prospectus supplement Apr 28, 2025 —
424B5 Prospectus supplement Mar 27, 2025 —
424B5 Prospectus supplement Mar 24, 2025 —
S-3 Shelf registration Mar 24, 2025 —
424B3 Prospectus Feb 3, 2025 —
S-3 Shelf registration Jan 24, 2025 —
424B5 Prospectus supplement Dec 10, 2024 —
424B3 Prospectus Nov 22, 2024 —
S-3 Shelf registration Nov 13, 2024 —
424B5 Prospectus supplement Sep 30, 2024 —
424B5 Prospectus supplement Sep 30, 2024 —
S-8 Employee stock plan registration Jun 5, 2024 —
424B5 Prospectus supplement May 8, 2024 —
424B5 Prospectus supplement Nov 7, 2023 —
424B3 Prospectus Oct 6, 2023 —
S-3/A Form s-3/a Sep 29, 2023 —
S-3 Shelf registration Sep 22, 2023 —
S-8 Employee stock plan registration Jun 16, 2023 —
424B5 Prospectus supplement Jun 16, 2023 —
424B5 Prospectus supplement Jun 16, 2023 —
S-3MEF Form s-3mef Jun 16, 2023 —
424B5 Prospectus supplement Jun 15, 2023 —
424B5 Prospectus supplement Mar 7, 2023 —
424B3 Prospectus Dec 20, 2022 —
424B5 Prospectus supplement Oct 31, 2022 —
424B5 Prospectus supplement Apr 26, 2022 —
S-3 Shelf registration Apr 14, 2022 —
424B3 Prospectus Jan 18, 2022 —
POS AM Post-effective amendment no. 1 to registration statement Jan 7, 2022 —
424B3 Prospectus Dec 14, 2021 —
424B3 Prospectus Dec 14, 2021 —
424B3 Prospectus Nov 10, 2021 —
424B3 Prospectus Nov 10, 2021 —
424B3 Prospectus Sep 29, 2021 —
424B3 Prospectus Sep 29, 2021 —
424B3 Prospectus Aug 11, 2021 —
424B3 Prospectus Aug 11, 2021 —
424B3 Prospectus Aug 2, 2021 —
S-1 Registration statement Jul 22, 2021 —
424B3 Prospectus Jul 16, 2021 —
424B3 Prospectus Jun 10, 2021 —
424B3 Prospectus May 24, 2021 —
424B3 Prospectus May 12, 2021 —
424B3 Prospectus Apr 21, 2021 —
S-8 Employee stock plan registration Mar 29, 2021 —
S-1/A Amended registration statement Mar 29, 2021 —
S-1 Registration statement Feb 17, 2021 —
424B3 Prospectus Dec 18, 2020 —
S-4/A Registration statement Dec 15, 2020 —
S-4/A Amendment no. 6 to form s-4 Dec 14, 2020 —
S-4/A Amendment no. 5 Dec 7, 2020 —
S-4/A Registration statement Nov 18, 2020 —
S-4/A Amendment no. 3 to form s-4 Oct 20, 2020 —
S-4/A Amendment no. 2 to form s-4 Oct 19, 2020 —
S-4/A Amendment no. 1 to form s-4 Sep 22, 2020 —
S-4 Registration for a merger or exchange Sep 10, 2020 —

Showing 67 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CLNN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Salt Lake City, UT
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1822791
Former names
Chelsea Worldwide Inc. (until Dec 18, 2020)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.